This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Live coverage has ended. The full story is below.
CoreWeave (NASDAQ: CRWV) reports Q4 2025 results today after the bell. This is only the company’s fourth earnings report since its March 2025 IPO, and it arrives under a cloud of litigation, insider selling, and a market hungry for 2026 guidance.
Legal Overhang Meets a Critical Inflection Point
Since Q3 results landed in November, CoreWeave’s story has gotten complicated. More than a dozen securities class action lawsuits have been filed, all centered on the same allegation: that CoreWeave misled investors about its ability to meet customer demand and understated its reliance on a single third-party data center supplier. The alleged class period runs from March 28 to December 15, 2025, with a lead plaintiff deadline of March 13, 2026.
The lawsuits specifically cite delays at the Denton, Texas data center tied to the Core Scientific partnership, which CoreWeave had already acknowledged on the Q3 call. CEO Michael Intrator framed it then as a temporary, isolated issue: “It’s not a challenge for power. There’s plenty of power right now… But really where the challenge is is the powered shell.” Tonight’s report is management’s first chance to show that narrative was accurate.
Adding to the pressure, CoreWeave’s Chief Development Officer sold shares worth roughly $3.5 million in mid-February, days before this report. The sales occurred under a pre-arranged trading plan, but the timing will draw scrutiny regardless.
Shares are up 21% year-to-date but down about 3% over the past month, sitting around $96 with an average analyst target of $126.
Consensus Estimates
Wall Street expects the following from Q4 earnings:
- Revenues: $1.53 billion
- EPS: -$.49
- EBITDA: $910 million
CoreWeave provided full-year revenue guidance of $5.05 billion to $5.15 billion on the Q3 call, implying Q4 revenue in the range of roughly $1.3 billion to $1.4 billion after the first three quarters totaled approximately $3.56 billion. Adjusted EBITDA margin guidance was 61% for the full year.
| Metric |
Q3 2025 Actual |
FY2025 Guidance |
| Revenue |
$1.365B |
$5.05B – $5.15B |
| Adj. EBITDA Margin |
61% |
~61% |
| Adj. Operating Income |
$217M |
$690M – $720M |
| Interest Expense |
$310.6M |
$1.21B – $1.25B |
| CapEx |
$3.279B |
$12B – $14B |
5 Things to Watch
- Data center delay resolution. Management said on the Q3 call that “the overwhelming majority of the delay… should be taken care of within Q1 of next year.” Q4 is the quarter that tests that promise. I’ll be watching whether the Denton delays actually compressed Q4 revenue and by how much.
- Active power deployment vs. the 850 MW target. CoreWeave guided for more than 850 MW of active power by year-end, up from 590 MW at the end of Q3. That would require adding roughly 260 MW in a single quarter. Whether they hit that number will be closely watched.
- The $55.6 billion backlog and whether it kept growing. Revenue backlog nearly doubled in Q3 alone, reaching $55.6 billion. You should watch whether Q4 adds meaningfully to that figure, and whether the largest customer’s share of backlog continues declining from the ~35% reported in Q3.
- 2026 guidance. CFO Nitin Agrawal said on the Q3 call that CoreWeave would “share more details on the 2026 build and our revenue plan… in the next earnings.” That’s tonight. The company also signaled CapEx would be “well in excess of double” 2025 levels. How management frames the path to profitability alongside that spending will set the tone for the stock in 2026.
- Litigation response and management credibility. With more than a dozen lawsuits alleging the company misled investors about infrastructure execution, tonight’s call is as much about tone as numbers. I’ll be listening closely to how Intrator addresses the Core Scientific situation and whether the company offers any clarity on legal exposure.
Contact [email protected] for any questions or corrections.